Recombinant FVII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A: Update of safety, efficacy and inhibitor development after seven study years

被引：0
|
作者：
Lusher, J
Arkin, S
Abildgaard, CF
Hurst, A
机构：
[1] MT SINAI SCH MED, NEW YORK, NY USA
[2] WAYNE STATE UNIV, DETROIT, MI USA
[3] UNIV CALIF DAVIS, SACRAMENTO, CA 95817 USA
[4] BAYER CORP, BERKELEY, CA USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PD664 / PD664
页数：1
相关论文
共 50 条
  • [41] Systematic Review of the Role of FVIII Concentrates in Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A: A 2013 Update
    Franchini, Massimo
    Coppola, Antonio
    Rocino, Angiola
    Santagostino, Elena
    Tagliaferri, Annarita
    Zanon, Ezio
    Morfini, Massimo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (07): : 752 - 766
  • [42] A clinical study in previously untreated patients with severe hemophilia A - Immunogenicity, efficacy and safety of treatment with human-cl rhFVIII
    Liesner, Raina
    Jansen, Martina
    Knaub, Sigurd
    HAEMOPHILIA, 2014, 20 : 17 - 17
  • [43] Initial studies of genetic factors development in previously inhibitor patients (PUPs) with hemophilia treated with recombinant factor VIII.
    Tuddenham, EGD
    Hoyer, L
    Hurst, D
    BLOOD, 1995, 86 (10) : 2429 - 2429
  • [44] Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan (vol 109, pg 70, 2019)
    Taki, Masashi
    Fukutake, Katsuyuki
    Matsushita, Tadashi
    Nogami, Keiji
    Shima, Midori
    Yoshioka, Akira
    Takamatsu, Junki
    Arai, Morio
    Takagi, Hiroshi
    Uchikawa, Haruhiko
    Engl, Werner
    Shirahata, Akira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (02) : 241 - 241
  • [45] Factor VIII prophylaxis and inhibitor development in previously untreated patients with severe hemophilia A: the RODIN study
    Gouw, S. C.
    Van den Berg, M.
    Auerswald, G.
    Carcao, M.
    Chalmers, E.
    Chambost, H.
    Fischer, K.
    Kurnik, K.
    Liesner, R.
    Petrini, P.
    Platokouki, H.
    Altisent, C.
    Oldenburg, J.
    Nolan, B.
    Perez Garido, R.
    Rafowicz, A.
    Williams, M.
    Van der Bom, J. G.
    HAEMOPHILIA, 2012, 18 : 3 - 4
  • [46] Guardian™ 4: safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated patients with hemophilia A
    Ozelo, M.
    Wu, R.
    Belhani, M.
    Lebedev, V.
    Yaish, H.
    Korsholm, L.
    Matytsina, I.
    Matsushita, T.
    HAEMOPHILIA, 2018, 24 : 101 - 102
  • [47] Factor VIII prophylaxis and inhibitor development in previously untreated patients with severe hemophilia A: The RODIN study
    Gouw, S.
    Van den Berg, H.
    Van der Bom, J.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [48] Exploration of biomarkers for early recognition of FVIII inhibitor development in previously untreated severe hemophilia A patients: Hemophilia Inhibitor PUP Study and beyond
    Hofbauer, C. J.
    Male, C.
    Brown, D.
    Santagostino, E.
    Oldenburg, J.
    Scheiflinger, F.
    Reipert, B. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 133 - 133
  • [49] Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin
    Liesner, Raina
    Abashidze, Marina
    Aleinikova, Olga
    Altisent, Carmen
    Belletrutti, Mark J.
    Borel-Derlon, Annie
    Carcao, Manuel
    Chambost, Herve
    Chan, Anthony
    Dubey, Leonid
    Ducore, Jonathan M.
    Abubacker, Fouzia Nambiathayil
    Gattens, Michael
    Gruel, Yves
    Kavardakova, Natalya
    Khorassani, Mohamed
    Klukowska, Anna
    Konigs, Christoph
    Lambert, Thierry
    Lohade, Sunil
    Sigaud, Marianne
    Turea, Valentin
    Wu, John K.
    Vdovin, Vladimir
    BLOOD, 2016, 128 (22)
  • [50] The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B
    Shapiro, AD
    Di Paola, J
    Cohen, A
    Pasi, KJ
    Heisel, MA
    Blanchette, VS
    Abshire, TC
    Hoots, WK
    Lusher, JM
    Negrier, C
    Rothschild, C
    Roth, DA
    BLOOD, 2005, 105 (02) : 518 - 525
12345